Welcome to our dedicated page for Diversified Healthcare Tr SEC filings (Ticker: DHC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Diversified Healthcare Trust filings document the reporting record of a Maryland real estate investment trust with Nasdaq-listed common shares of beneficial interest and listed senior notes. Its Form 8-K filings cover quarterly operating results, earnings presentations, Regulation FD investor presentations and other material-event disclosures tied to its healthcare real estate portfolio.
DHC proxy materials disclose shareholder voting matters, trustee governance and annual meeting procedures. The filings also document capital-structure items, including senior notes, and management-related disclosures under agreements with The RMR Group, including incentive management fee reporting, risk disclosures and financial statement effects.
Diversified Healthcare Trust furnished a new investor presentation, dated May 5, 2026, and made it available on its website. The presentation is attached as Exhibit 99.1 to this Form 8-K. This is an informational update rather than a disclosure of specific new financial results or major transactions.
Diversified Healthcare Trust reported first‑quarter 2026 revenue of $366.5 million, down from $386.9 million a year earlier, as it continued reshaping its portfolio. The company posted a net loss of $43.3 million, or $0.18 per share, compared with a $9.0 million loss, mainly because last year included a large gain on property sales.
Property performance was steadier: consolidated NOI rose to $75.9 million from $72.5 million. The senior housing operating portfolio (SHOP) improved, with NOI increasing to $43.6 million on higher occupancy and rates, while medical office and life science NOI eased to $25.1 million, partly reflecting asset sales. Interest expense fell to $37.0 million from $57.8 million after prior debt redemptions.
On a cash‑flow basis, FFO was $22.8 million and Normalized FFO was $33.1 million, both higher than a year ago, supported by lower interest costs and the absence of impairment charges. The REIT ended the quarter with $139.9 million in cash and restricted cash and maintained its quarterly dividend at $0.01 per share.
Diversified Healthcare Trust reported first quarter 2026 revenue of $366.5 million and a net loss of $43.3 million, or $0.18 per share. The loss narrowed compared to the prior year as operating metrics improved.
Same property senior housing operating (SHOP) performance strengthened, with same property SHOP NOI of $44.3 million, up 13.5% year over year, and NOI margins rising to 14.9%. Medical office and life science same property cash basis NOI grew 3.0% year over year, and occupancy reached 95.3%.
Normalized FFO was $33.1 million, or $0.14 per share, more than double the prior-year quarter, while Adjusted EBITDAre was $74.0 million. Leverage improved, with net debt to annualized Adjusted EBITDAre at 7.8x and Adjusted EBITDAre to interest expense at 2.0x. Liquidity totaled $271 million, including $121 million of cash and an undrawn $150 million secured revolver.
For full year 2026, DHC guides to total NOI of $297–313 million and Normalized FFO of $125–140 million ($0.52–0.58 per share), driven by expected 26–33% SHOP NOI growth and stable medical office and life science results. The company declared a quarterly common dividend of $0.01 per share.
The Vanguard Group filed Amendment No. 2 on a Schedule 13G/A reporting its position in Diversified Healthcare Trust common stock. The filing states amount beneficially owned: 0 shares representing 0%. The filing explains an internal realignment on January 12, 2026 that led certain Vanguard subsidiaries and business divisions to report beneficial ownership separately. The disclosure is signed by Ashley Grim, Head of Global Fund Administration, dated 03/26/2026.
Diversified Healthcare Trust is asking shareholders to vote at its virtual 2026 annual meeting on June 10 on three items: elect seven trustees, approve executive compensation on an advisory basis, and ratify Deloitte & Touche as auditor.
The proxy highlights 2025 actions: sale of 69 non-core properties for about $605 million, using proceeds and cash on hand to fully repay 2026 zero coupon senior secured notes, leaving no debt maturities until 2028. The company also transitioned 116 senior housing operating communities to new managers, expects improvements in occupancy, rates and NOI, and reports it was the top-performing U.S. REIT in 2025 with total shareholder return of roughly 113%.
The filing details a seven-member board with five independent trustees, a lead independent trustee role, committee structures, shareholder engagement, and extensive sustainability and SASB-aligned metrics on energy, water, climate risk and tenant engagement, along with trustee compensation and ownership guidelines.
Diversified Healthcare Trust filed a current report stating that it has posted a new investor presentation on its website. The presentation, dated February 24, 2026, is included as Exhibit 99.1 and is furnished as part of the disclosure to provide investors with updated information about the company.
Diversified Healthcare Trust files its 2025 annual report outlining a large U.S. healthcare real estate platform focused on senior living, medical office and life science properties. As of December 31, 2025, it owned 298 properties across 33 states and Washington, D.C., plus interests in two joint ventures.
The joint ventures own about 2.2 million rentable square feet that were 99% leased with a 14.2-year average remaining lease term. DHC emphasizes senior housing demand from an aging U.S. population, selective acquisitions and dispositions, development and repositioning, and extensive use of third-party managers under TRS structures, while highlighting significant regulatory, reimbursement, financing and operational risks.
Diversified Healthcare Trust reported a Q4 2025 net loss of $21.2 million, or $0.09 per share, but significantly stronger cash metrics, including normalized FFO of $21.8 million, or $0.09 per share, and Adjusted EBITDAre of $72.4 million. Same property senior housing operating portfolio (SHOP) cash NOI rose 27.6% year over year to $38.3 million, driven by 82.4% occupancy and a 5.8% increase in average monthly rates. The medical office and life science portfolio generated same property cash NOI of $24.1 million with 94.7% occupancy.
For full year 2025, DHC posted a net loss of $285.9 million, impacted by $165.7 million of impairments and high interest expense, while normalized FFO improved to $64.4 million. Management highlighted approximately $6.3 billion of real estate across 298 properties and noted it fully redeemed its zero‑coupon notes due 2026, reducing net debt to annualized Adjusted EBITDAre to 8.1x. The company issued 2026 guidance calling for NOI of $297–$313 million, Adjusted EBITDAre of $290–$305 million, and normalized FFO of $125–$140 million, with expected SHOP NOI growth of 26%–33%.
Diversified Healthcare Trust reported two key items. First, it incurred an incentive management fee of $17.9 million for the 2025 calendar year under its Business Management Agreement with The RMR Group LLC. This fee is payable in cash by January 30, 2026 and will be recorded as an expense in the company’s financial statements for the year ended December 31, 2025.
Second, on January 9, 2026, the company received a cash dividend of $27.2 million from AlerisLife Inc. in connection with AlerisLife’s sale of all assets and wind-down of its business. Diversified Healthcare Trust expects to receive an additional cash dividend of approximately $3.0 million to $7.0 million upon completion of that wind-down, though the amount or timing may change.